SEC Filing Summary

This filing details a Form 4 for BridgeBio Oncology Therapeutics, Inc. (BBOT), reporting changes in beneficial ownership. Specifically, it grants a stock option (Right to Buy) for 31,675 shares of Common Stock to Praveen P. Tipirneni, a director. The option has an exercise price of $7.73 and an expiration date of June 15, 2036. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date or the date of the next Annual Meeting of Stockholders, subject to continued service. The filing also includes a Limited Power of Attorney, authorizing specific individuals to execute SEC forms on behalf of the undersigned, including Forms 3, 4, 5, and Schedules 13D/13G.